Fluorine in PDB 6x3o: Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor
Enzymatic activity of Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor
All present enzymatic activity of Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor:
2.7.10.2;
Protein crystallography data
The structure of Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor, PDB code: 6x3o
was solved by
T.O.Fischmann,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
34.79 /
1.90
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
38.300,
72.010,
104.390,
90.00,
91.40,
90.00
|
R / Rfree (%)
|
17.9 /
21.3
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor
(pdb code 6x3o). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor, PDB code: 6x3o:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 6x3o
Go back to
Fluorine Binding Sites List in 6x3o
Fluorine binding site 1 out
of 6 in the Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F701
b:51.4
occ:1.00
|
F35
|
A:ULY701
|
0.0
|
51.4
|
1.0
|
C34
|
A:ULY701
|
1.3
|
48.9
|
1.0
|
F37
|
A:ULY701
|
2.1
|
48.9
|
1.0
|
F36
|
A:ULY701
|
2.1
|
49.5
|
1.0
|
C32
|
A:ULY701
|
2.4
|
42.6
|
1.0
|
C33
|
A:ULY701
|
2.8
|
39.4
|
1.0
|
CZ
|
A:PHE442
|
3.5
|
53.8
|
1.0
|
C31
|
A:ULY701
|
3.6
|
41.0
|
1.0
|
CE1
|
A:PHE442
|
3.7
|
54.3
|
1.0
|
CD1
|
A:ILE472
|
3.9
|
33.4
|
1.0
|
CG2
|
A:ILE472
|
3.9
|
29.7
|
1.0
|
C28
|
A:ULY701
|
4.2
|
37.5
|
1.0
|
CG1
|
A:ILE472
|
4.2
|
30.1
|
1.0
|
CB
|
A:ALA446
|
4.2
|
51.8
|
1.0
|
CD2
|
A:LEU542
|
4.3
|
39.5
|
1.0
|
O26
|
A:ULY701
|
4.4
|
40.1
|
1.0
|
CE2
|
A:PHE442
|
4.5
|
55.5
|
1.0
|
CD1
|
A:LEU542
|
4.6
|
37.1
|
1.0
|
CD1
|
A:PHE442
|
4.7
|
53.2
|
1.0
|
CB
|
A:ILE472
|
4.7
|
29.9
|
1.0
|
C30
|
A:ULY701
|
4.7
|
39.6
|
1.0
|
CA
|
A:ALA446
|
4.8
|
51.2
|
1.0
|
N29
|
A:ULY701
|
5.0
|
38.2
|
1.0
|
CD2
|
A:LEU460
|
5.0
|
37.6
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 6x3o
Go back to
Fluorine Binding Sites List in 6x3o
Fluorine binding site 2 out
of 6 in the Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F701
b:49.5
occ:1.00
|
F36
|
A:ULY701
|
0.0
|
49.5
|
1.0
|
C34
|
A:ULY701
|
1.3
|
48.9
|
1.0
|
F35
|
A:ULY701
|
2.1
|
51.4
|
1.0
|
F37
|
A:ULY701
|
2.1
|
48.9
|
1.0
|
C32
|
A:ULY701
|
2.4
|
42.6
|
1.0
|
C31
|
A:ULY701
|
3.2
|
41.0
|
1.0
|
C33
|
A:ULY701
|
3.3
|
39.4
|
1.0
|
CD1
|
A:LEU460
|
3.3
|
36.9
|
1.0
|
CB
|
A:ALA446
|
3.7
|
51.8
|
1.0
|
CA
|
A:ALA446
|
3.8
|
51.2
|
1.0
|
CD2
|
A:LEU460
|
3.9
|
37.6
|
1.0
|
CG
|
A:LEU460
|
4.1
|
35.9
|
1.0
|
O
|
A:ALA446
|
4.3
|
56.1
|
1.0
|
CE
|
A:MET450
|
4.3
|
65.0
|
1.0
|
C30
|
A:ULY701
|
4.4
|
39.6
|
1.0
|
SD
|
A:MET449
|
4.4
|
61.5
|
1.0
|
CB
|
A:MET449
|
4.5
|
54.6
|
1.0
|
C28
|
A:ULY701
|
4.5
|
37.5
|
1.0
|
CG2
|
A:ILE472
|
4.5
|
29.7
|
1.0
|
C
|
A:ALA446
|
4.5
|
56.8
|
1.0
|
CB
|
A:LEU460
|
4.7
|
29.4
|
1.0
|
N
|
A:ALA446
|
4.9
|
51.0
|
1.0
|
N29
|
A:ULY701
|
5.0
|
38.2
|
1.0
|
CG
|
A:MET449
|
5.0
|
57.9
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 6x3o
Go back to
Fluorine Binding Sites List in 6x3o
Fluorine binding site 3 out
of 6 in the Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F701
b:48.9
occ:1.00
|
F37
|
A:ULY701
|
0.0
|
48.9
|
1.0
|
C34
|
A:ULY701
|
1.3
|
48.9
|
1.0
|
F35
|
A:ULY701
|
2.1
|
51.4
|
1.0
|
F36
|
A:ULY701
|
2.1
|
49.5
|
1.0
|
C32
|
A:ULY701
|
2.4
|
42.6
|
1.0
|
C31
|
A:ULY701
|
2.9
|
41.0
|
1.0
|
CD2
|
A:LEU542
|
3.3
|
39.5
|
1.0
|
SD
|
A:MET449
|
3.5
|
61.5
|
1.0
|
C33
|
A:ULY701
|
3.6
|
39.4
|
1.0
|
CA
|
A:ALA446
|
3.8
|
51.2
|
1.0
|
CB
|
A:ALA446
|
3.8
|
51.8
|
1.0
|
CE1
|
A:PHE442
|
4.1
|
54.3
|
1.0
|
C30
|
A:ULY701
|
4.2
|
39.6
|
1.0
|
N
|
A:ALA446
|
4.3
|
51.0
|
1.0
|
CG
|
A:LEU542
|
4.5
|
36.2
|
1.0
|
CZ
|
A:PHE442
|
4.6
|
53.8
|
1.0
|
CD1
|
A:PHE442
|
4.6
|
53.2
|
1.0
|
CG
|
A:MET449
|
4.6
|
57.9
|
1.0
|
CD1
|
A:LEU542
|
4.7
|
37.1
|
1.0
|
C28
|
A:ULY701
|
4.7
|
37.5
|
1.0
|
CB
|
A:MET449
|
4.8
|
54.6
|
1.0
|
CE
|
A:MET449
|
4.8
|
58.3
|
1.0
|
O
|
A:PHE442
|
4.8
|
52.2
|
1.0
|
CD1
|
A:LEU460
|
4.8
|
36.9
|
1.0
|
C
|
A:GLU445
|
5.0
|
54.5
|
1.0
|
N29
|
A:ULY701
|
5.0
|
38.2
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 6x3o
Go back to
Fluorine Binding Sites List in 6x3o
Fluorine binding site 4 out
of 6 in the Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F701
b:41.5
occ:1.00
|
F35
|
B:ULY701
|
0.0
|
41.5
|
1.0
|
C34
|
B:ULY701
|
1.3
|
42.3
|
1.0
|
F37
|
B:ULY701
|
2.1
|
45.5
|
1.0
|
F36
|
B:ULY701
|
2.1
|
40.0
|
1.0
|
C32
|
B:ULY701
|
2.4
|
38.6
|
1.0
|
C33
|
B:ULY701
|
2.9
|
35.2
|
1.0
|
CZ
|
B:PHE442
|
3.3
|
58.9
|
1.0
|
C31
|
B:ULY701
|
3.5
|
37.0
|
1.0
|
CE1
|
B:PHE442
|
3.6
|
59.4
|
1.0
|
CD2
|
B:LEU542
|
3.7
|
39.2
|
1.0
|
CD1
|
B:ILE472
|
4.2
|
39.4
|
1.0
|
CE2
|
B:PHE442
|
4.2
|
60.7
|
1.0
|
C28
|
B:ULY701
|
4.2
|
33.0
|
1.0
|
CD1
|
B:LEU542
|
4.3
|
34.6
|
1.0
|
CB
|
B:ALA446
|
4.3
|
72.7
|
1.0
|
CG2
|
B:ILE472
|
4.4
|
30.3
|
1.0
|
CD1
|
B:PHE442
|
4.6
|
58.4
|
1.0
|
C30
|
B:ULY701
|
4.6
|
33.8
|
1.0
|
CG
|
B:LEU542
|
4.6
|
34.7
|
1.0
|
CG1
|
B:ILE472
|
4.7
|
30.8
|
1.0
|
O26
|
B:ULY701
|
4.7
|
29.7
|
1.0
|
CA
|
B:ALA446
|
4.9
|
72.0
|
1.0
|
N29
|
B:ULY701
|
5.0
|
32.4
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 6x3o
Go back to
Fluorine Binding Sites List in 6x3o
Fluorine binding site 5 out
of 6 in the Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F701
b:40.0
occ:1.00
|
F36
|
B:ULY701
|
0.0
|
40.0
|
1.0
|
C34
|
B:ULY701
|
1.3
|
42.3
|
1.0
|
F37
|
B:ULY701
|
2.1
|
45.5
|
1.0
|
F35
|
B:ULY701
|
2.1
|
41.5
|
1.0
|
C32
|
B:ULY701
|
2.3
|
38.6
|
1.0
|
C33
|
B:ULY701
|
3.0
|
35.2
|
1.0
|
CD2
|
B:LEU460
|
3.2
|
40.2
|
1.0
|
C31
|
B:ULY701
|
3.4
|
37.0
|
1.0
|
CD1
|
B:LEU460
|
3.4
|
37.4
|
1.0
|
CG
|
B:LEU460
|
3.9
|
36.5
|
1.0
|
CG2
|
B:ILE472
|
3.9
|
30.3
|
1.0
|
CB
|
B:ALA446
|
4.2
|
72.7
|
1.0
|
C28
|
B:ULY701
|
4.3
|
33.0
|
1.0
|
CA
|
B:ALA446
|
4.5
|
72.0
|
1.0
|
C30
|
B:ULY701
|
4.5
|
33.8
|
1.0
|
CB
|
B:LEU460
|
4.7
|
29.0
|
1.0
|
O
|
B:ALA446
|
4.8
|
77.0
|
1.0
|
CD1
|
B:ILE472
|
4.9
|
39.4
|
1.0
|
CG1
|
B:VAL463
|
4.9
|
37.1
|
1.0
|
CB
|
B:MET449
|
4.9
|
68.3
|
1.0
|
N29
|
B:ULY701
|
4.9
|
32.4
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 6x3o
Go back to
Fluorine Binding Sites List in 6x3o
Fluorine binding site 6 out
of 6 in the Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Co-Structure of Btk Kinase Domain with L-005191930 Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F701
b:45.5
occ:1.00
|
F37
|
B:ULY701
|
0.0
|
45.5
|
1.0
|
C34
|
B:ULY701
|
1.3
|
42.3
|
1.0
|
F36
|
B:ULY701
|
2.1
|
40.0
|
1.0
|
F35
|
B:ULY701
|
2.1
|
41.5
|
1.0
|
C32
|
B:ULY701
|
2.4
|
38.6
|
1.0
|
C31
|
B:ULY701
|
2.8
|
37.0
|
1.0
|
SD
|
B:MET449
|
3.4
|
76.4
|
1.0
|
C33
|
B:ULY701
|
3.6
|
35.2
|
1.0
|
CA
|
B:ALA446
|
3.7
|
72.0
|
1.0
|
CD2
|
B:LEU542
|
3.8
|
39.2
|
1.0
|
CB
|
B:MET449
|
3.9
|
68.3
|
1.0
|
CB
|
B:ALA446
|
3.9
|
72.7
|
1.0
|
CE
|
B:MET449
|
3.9
|
73.0
|
1.0
|
CG
|
B:MET449
|
4.0
|
71.9
|
1.0
|
C30
|
B:ULY701
|
4.1
|
33.8
|
1.0
|
CD2
|
B:LEU460
|
4.5
|
40.2
|
1.0
|
N
|
B:ALA446
|
4.5
|
71.9
|
1.0
|
O
|
B:ALA446
|
4.7
|
77.0
|
1.0
|
C28
|
B:ULY701
|
4.8
|
33.0
|
1.0
|
C
|
B:ALA446
|
4.8
|
77.0
|
1.0
|
CZ
|
B:PHE442
|
4.9
|
58.9
|
1.0
|
CE1
|
B:PHE442
|
5.0
|
59.4
|
1.0
|
N29
|
B:ULY701
|
5.0
|
32.4
|
1.0
|
CG
|
B:LEU542
|
5.0
|
34.7
|
1.0
|
|
Reference:
J.Liu,
D.Guiadeen,
A.Krikorian,
X.Gao,
J.Wang,
S.Babu Boga,
A.B.Alhassan,
W.Yu,
O.Selyutin,
Y.Yu,
R.Anand,
J.Xu,
J.Kelly,
J.L.Duffy,
S.Liu,
C.Yang,
H.Wu,
J.Cai,
C.Bennett,
K.M.Maloney,
S.Tyagarajan,
Y.D.Gao,
T.O.Fischmann,
J.Presland,
M.Mansueto,
Z.Xu,
E.Leccese,
J.Zhang-Hoover,
I.Knemeyer,
C.G.Garlisi,
P.Stivers,
P.E.Brandish,
A.Hicks,
R.Kim,
J.A.Kozlowski.
Potent, Non-Covalent Reversible Btk Inhibitors with 8-Amino-Imidazo[1,5-A]Pyrazine Core Featuring 3-Position Bicyclic Ring Substitutes. Bioorg.Med.Chem.Lett. V. 30 27390 2020.
ISSN: ESSN 1464-3405
PubMed: 32738973
DOI: 10.1016/J.BMCL.2020.127390
Page generated: Fri Aug 2 03:59:27 2024
|